AT98487T - Aerosoltraeger. - Google Patents

Aerosoltraeger.

Info

Publication number
AT98487T
AT98487T AT91902428T AT91902428T AT98487T AT 98487 T AT98487 T AT 98487T AT 91902428 T AT91902428 T AT 91902428T AT 91902428 T AT91902428 T AT 91902428T AT 98487 T AT98487 T AT 98487T
Authority
AT
Austria
Prior art keywords
aerosoltraeger
Prior art date
Application number
AT91902428T
Other languages
German (de)
Inventor
David Ganderton
Nuha Mohammed Kassem
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB909001635A priority Critical patent/GB9001635D0/en
Application filed by British Tech Group filed Critical British Tech Group
Priority to EP19910902428 priority patent/EP0464171B1/en
Priority to PCT/GB1991/000103 priority patent/WO1991011179A1/en
Publication of AT98487T publication Critical patent/AT98487T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
AT91902428T 1990-01-24 1991-01-24 Aerosoltraeger. AT98487T (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB909001635A GB9001635D0 (en) 1990-01-24 1990-01-24 Aerosol carriers
EP19910902428 EP0464171B1 (en) 1990-01-24 1991-01-24 Aerosol carriers
PCT/GB1991/000103 WO1991011179A1 (en) 1990-01-24 1991-01-24 Aerosol carriers

Publications (1)

Publication Number Publication Date
AT98487T true AT98487T (en) 1994-01-15

Family

ID=10669832

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91902428T AT98487T (en) 1990-01-24 1991-01-24 Aerosoltraeger.

Country Status (14)

Country Link
US (1) US5254330A (en)
EP (1) EP0464171B1 (en)
JP (1) JP3100626B2 (en)
AT (1) AT98487T (en)
AU (1) AU635616B2 (en)
CA (1) CA2049302C (en)
DE (2) DE69100792T2 (en)
FI (1) FI914460A0 (en)
GB (2) GB9001635D0 (en)
HU (1) HUT59821A (en)
IE (1) IE910222A1 (en)
NO (1) NO913731L (en)
PT (1) PT96567A (en)
WO (1) WO1991011179A1 (en)

Families Citing this family (128)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT77947T (en) * 1987-04-09 1992-07-15 Fisons Plc Pentamidine pharmaceutical compositions containing them.
US5376386A (en) * 1990-01-24 1994-12-27 British Technology Group Limited Aerosol carriers
US5993805A (en) * 1991-04-10 1999-11-30 Quadrant Healthcare (Uk) Limited Spray-dried microparticles and their use as therapeutic vehicles
US6673335B1 (en) * 1992-07-08 2004-01-06 Nektar Therapeutics Compositions and methods for the pulmonary delivery of aerosolized medicaments
US6509006B1 (en) 1992-07-08 2003-01-21 Inhale Therapeutic Systems, Inc. Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
AT145819T (en) * 1992-03-10 1996-12-15 Fisons Plc inhalable drug
ES2177544T3 (en) * 1992-06-12 2002-12-16 Teijin Ltd ultrafinno powder inhaler and method for its preparation.
US5780014A (en) * 1995-04-14 1998-07-14 Inhale Therapeutic Systems Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
US6051256A (en) * 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
IS1796B (en) * 1993-06-24 2001-12-31 Ab Astra The polypeptide formulation for inhalation further comprising an enhancer compound
TW402506B (en) 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
US6794357B1 (en) 1993-06-24 2004-09-21 Astrazeneca Ab Compositions for inhalation
US20010003739A1 (en) * 1993-06-24 2001-06-14 Astrazeneca Ab Systemic administration of a therapeutic preparation
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US6165976A (en) 1994-06-23 2000-12-26 Astra Aktiebolag Therapeutic preparation for inhalation
US5830853A (en) 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
US5747445A (en) * 1993-06-24 1998-05-05 Astra Aktiebolag Therapeutic preparation for inhalation
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
AUPM411494A0 (en) * 1994-02-25 1994-03-24 Central Sydney Area Health Service Method and device for the provocation of upper or lower airway narrowing and/or the induction of sputum
CZ295827B6 (en) 1994-03-07 2005-11-16 Nektar Therapeutics Method for aerosolizing a dose of insulin, insulin composition and use thereof
US5536249A (en) * 1994-03-09 1996-07-16 Visionary Medical Products, Inc. Pen-type injector with a microprocessor and blood characteristic monitor
GB9404945D0 (en) * 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
US5641510A (en) * 1994-07-01 1997-06-24 Genentech, Inc. Method for treating capsules used for drug storage
DE4425255A1 (en) * 1994-07-16 1996-01-18 Asta Medica Ag Formulation for inhalation
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
MY131733A (en) 1994-12-22 2007-08-30 Astra Ab Aerosol drug formulations
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
AT238043T (en) * 1994-12-22 2003-05-15 Astrazeneca Ab Parathyroid hormone PTH-containing therapeutic formulation for inhalation
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US5612053A (en) 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
SE9501384D0 (en) * 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
US6428771B1 (en) 1995-05-15 2002-08-06 Pharmaceutical Discovery Corporation Method for drug delivery to the pulmonary system
AU1860697A (en) * 1995-09-08 1997-07-28 Visionary Medical Products Corporation Pen-type injector drive mechanism
FR2742164B1 (en) * 1995-12-11 1999-01-29 Beghin Say Eridania Sugar microcrystalline, composition and method for obtaining
US5699789A (en) * 1996-03-11 1997-12-23 Hendricks; Mark R. Dry powder inhaler
US20030203036A1 (en) 2000-03-17 2003-10-30 Gordon Marc S. Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
US6001336A (en) 1996-12-31 1999-12-14 Inhale Therapeutic Systems Processes for spray drying aqueous suspensions of hydrophobic drugs and compositions thereof
GB9703673D0 (en) * 1997-02-21 1997-04-09 Bradford Particle Design Ltd Method and apparatus for the formation of particles
US6129905A (en) * 1997-04-21 2000-10-10 Aeropharm Technology, Inc. Aerosol formulations containing a sugar as a dispersant
US5891419A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
EP0876814A1 (en) * 1997-05-07 1998-11-11 "PHARLYSE", Société Anonyme Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it
SE9701956D0 (en) 1997-05-23 1997-05-23 Astra Ab New composition of matter
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6946117B1 (en) * 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
HU0004821A2 (en) * 1997-12-03 2001-06-28 Fujisawa Pharmaceutical Co., Ltd. Preparation and pharmaceutical compositions in the form of soft pellets
GB9806477D0 (en) * 1998-03-26 1998-05-27 Glaxo Group Ltd Improved crystals
US6489183B1 (en) * 1998-07-17 2002-12-03 Micron Technology, Inc. Method of manufacturing a taped semiconductor device
US6136294C1 (en) * 1998-09-22 2002-09-24 Aeropharm Technology Inc Amino acid stabilized medical aerosol formulation
US6458338B1 (en) 1998-09-22 2002-10-01 Aeropharm Technology Incorporated Amino acid stabilized medicinal aerosol formulations
PL200941B1 (en) 1998-11-13 2009-02-27 Jagotec Ag Dry powder for inhalation
US20070212422A1 (en) * 1999-11-10 2007-09-13 Manfred Keller Dry powder for inhalation
WO2000035417A1 (en) * 1998-12-11 2000-06-22 Pharmachemie B.V. Pharmaceutical preparation for inhalation of an opioid
WO2000062819A1 (en) 1999-04-21 2000-10-26 1355540 Ontario Inc. Formulations for detecting asthma
DK1808438T3 (en) 1999-06-29 2014-10-27 Mannkind Corp Purification and stabilization of peptide and protein drugs in
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
ES2165768B1 (en) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa New quinuclidine derivatives and pharmaceutical compositions containing them.
ITMI991582A1 (en) * 1999-07-16 2001-01-16 Chiesi Farma Spa Powder consisting of particles having a perfectly smooth surface to be used as vehicles for the preparation of mixtures inhales
WO2001077328A1 (en) * 2000-04-06 2001-10-18 Franco Wayne P Methods of using growth factors for treating heart disease
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
ES2525087T5 (en) 2000-05-10 2018-06-28 Novartis Ag phospholipid based powders drug delivery
US7575761B2 (en) 2000-06-30 2009-08-18 Novartis Pharma Ag Spray drying process control of drying kinetics
AU7977101A (en) * 2000-07-20 2002-02-05 Campina Melkunie Bv Carrier material for dry powder inhalation
AU2002211311B2 (en) * 2000-10-09 2006-08-31 3M Innovative Properties Company Medicinal aerosol formulations
US20100310477A1 (en) * 2000-11-28 2010-12-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical compositions based on anticholingerics and additional active ingredients
GB0027357D0 (en) 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
GB0030074D0 (en) * 2000-12-08 2001-01-24 Univ London Pharmacy Particulate inhalation carrier
DE10141377A1 (en) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Sprinkling method for preparation of powder formulations
DE10141376A1 (en) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Process for preparing inhalable powders
US20050013862A1 (en) * 2001-09-05 2005-01-20 Vectura Limited Functional powders for oral delivery
AU2002366267B2 (en) * 2001-11-19 2007-05-10 Becton, Dickinson And Company Pharmaceutical compositions in particulate form
MXPA04005865A (en) 2001-12-19 2004-09-13 Nektar Therapeutics Pulmonary delivery of aminoglycosides.
AU2003209475A1 (en) * 2002-03-07 2003-09-16 Vectura Limited Fast melt multiparticulate formulations for oral delivery
EP1894591B1 (en) 2002-03-20 2013-06-26 MannKind Corporation Cartridge for an inhalation apparatus
AU2002308143A1 (en) * 2002-04-12 2003-10-27 Campina Nederland Holding B.V. Excipient for use in dry powder inhalation preparations
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
GB0216562D0 (en) 2002-04-25 2002-08-28 Bradford Particle Design Ltd Particulate materials
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
CA2483914A1 (en) * 2002-05-07 2003-11-20 Nektar Therapeutics Capsules for dry powder inhalers and methods of making and using same
AU2003233119A1 (en) 2002-05-08 2003-11-11 Neuronova Ab Modulation of neural stem cells with s1p or lpa receptor agonists
GB0210527D0 (en) * 2002-05-08 2002-06-19 Univ Bath Process for the treatment of particles for use in pharmaceutical formulations
WO2005004845A1 (en) 2003-07-11 2005-01-20 Glaxo Group Limited Pharmaceutical formulations comprising magnesium stearate
US20050026887A1 (en) * 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a steroid
JP4861177B2 (en) * 2003-09-12 2012-01-25 ニューロノバ エービー Treatment of disorders of the nervous system
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
CA2576410A1 (en) * 2003-09-18 2006-03-31 Norton Healthcare Ltd. Particles
US20080090753A1 (en) 2004-03-12 2008-04-17 Biodel, Inc. Rapid Acting Injectable Insulin Compositions
CN101098678A (en) 2004-04-23 2008-01-02 锡德克斯公司 Dpi formulation containing sulfoalkyl ether cyclodextrin
AU2005277208B2 (en) 2004-08-20 2011-11-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
DK2322180T3 (en) 2004-08-23 2015-06-15 Mannkind Corp Diketopiperazinsalte for drug delivery
EP1858528A2 (en) * 2005-02-10 2007-11-28 Glaxo Group Limited Process for crystallizing lactose particles for use in pharmaceutical formulations
ES2613391T3 (en) 2005-02-10 2017-05-24 Glaxo Group Limited Lactose manufacturing processes using presorting techniques and pharmaceutical formulations formed therefrom
US8062670B2 (en) * 2005-08-05 2011-11-22 3M Innovative Properties Company Compositions exhibiting improved flowability
KR20120060245A (en) 2005-09-14 2012-06-11 맨카인드 코포레이션 Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
AU2007238114B2 (en) 2006-04-12 2010-10-14 Biodel, Inc. Rapid acting and long acting insulin combination formulations
US8084420B2 (en) 2005-09-29 2011-12-27 Biodel Inc. Rapid acting and long acting insulin combination formulations
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
JP5599975B2 (en) 2006-02-22 2014-10-01 マンカインド コーポレイション Method for improving the formulation properties of the fine particles containing diketopiperazine and an active agent
US7713929B2 (en) 2006-04-12 2010-05-11 Biodel Inc. Rapid acting and long acting insulin combination formulations
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
JP2010500356A (en) * 2006-08-09 2010-01-07 グラクソ グループ リミテッドGlaxo Group Limited Method for producing lactose
EP2425819A1 (en) 2007-02-11 2012-03-07 MAP Pharmaceuticals Inc Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
US8785396B2 (en) 2007-10-24 2014-07-22 Mannkind Corporation Method and composition for treating migraines
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
DK2570147T3 (en) 2008-06-13 2018-01-29 Mannkind Corp Dry powder inhaler and system for drug administration
RU2470681C2 (en) 2008-06-20 2012-12-27 Маннкайнд Корпорейшн Interactive system and method for real-time force profiling in inhalation
TWI614024B (en) 2008-08-11 2018-02-11 Mannkind Corp Use of ultrarapid acting insulin
EP2191821A1 (en) 2008-11-26 2010-06-02 CHIESI FARMACEUTICI S.p.A. Microparticles comprising a salt of 8-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone having improved adhesion properties for dry powder inhalation
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9060927B2 (en) 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
DK2405963T3 (en) 2009-03-11 2013-12-16 Mannkind Corp An apparatus, system and method for measuring resistance in an inhaler
BRPI1013154A2 (en) 2009-06-12 2016-04-05 Mannkind Corp microparticles of diketopiperazine with specific surface areas defined.
EP2496295A1 (en) 2009-11-03 2012-09-12 MannKind Corporation An apparatus and method for simulating inhalation efforts
AU2011271097B2 (en) 2010-06-21 2014-11-27 Mannkind Corporation Dry powder drug delivery system and methods
TR201007250A2 (en) 2010-09-01 2012-03-21 Bilgiç Mahmut The formulation containing cellobiose.
US9808030B2 (en) 2011-02-11 2017-11-07 Grain Processing Corporation Salt composition
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
AU2012328885B2 (en) 2011-10-24 2017-08-31 Mannkind Corporation Methods and compositions for treating pain
SG11201500218VA (en) 2012-07-12 2015-03-30 Mannkind Corp Dry powder drug delivery systems and methods
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
CA2918369A1 (en) 2013-07-18 2015-01-22 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE292149C (en) *
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate
SE7812207A (en) * 1977-12-01 1979-06-02 Welsh Nat School Med Apparatus, method, and framstellda products for priority over the administration of antihistamines
US4349542A (en) * 1979-06-08 1982-09-14 National Research Development Corporation Mixture containing active ingredient and dendritic crystalline sugar for tableting
CY1333A (en) * 1980-04-30 1986-10-24 Fisons Ltd Pharmaceutical compositions containing cromoglycates
JPS6237016B2 (en) * 1983-03-09 1987-08-10 Teijin Ltd
EP0248051A1 (en) * 1985-11-29 1987-12-09 FISONS plc Pharmaceutical composition including sodium cromoglycate
US4940556A (en) * 1986-01-30 1990-07-10 Syntex (U.S.A.) Inc. Method of preparing long acting formulation
IT1204826B (en) * 1986-03-04 1989-03-10 Chiesi Farma Spa Pharmaceutical compositions for inhalation
GB8712176D0 (en) * 1987-05-22 1987-06-24 Cosmas Damian Ltd Drug delivery system

Also Published As

Publication number Publication date
IE910222A1 (en) 1991-07-31
AU635616B2 (en) 1993-03-25
WO1991011179A1 (en) 1991-08-08
HU913284D0 (en) 1992-01-28
AU7155991A (en) 1991-08-21
NO913731D0 (en) 1991-09-23
GB2240337A (en) 1991-07-31
CA2049302C (en) 2001-05-29
EP0464171B1 (en) 1993-12-15
GB2240337B (en) 1993-02-24
NO913731L (en) 1991-11-21
GB9101551D0 (en) 1991-03-06
DE69100792T2 (en) 1994-04-14
JPH04504427A (en) 1992-08-06
DE69100792D1 (en) 1994-01-27
PT96567A (en) 1991-10-15
FI914460D0 (en)
US5254330A (en) 1993-10-19
EP0464171A1 (en) 1992-01-08
GB9001635D0 (en) 1990-03-21
JP3100626B2 (en) 2000-10-16
CA2049302A1 (en) 1991-07-25
FI914460A0 (en) 1991-09-23
HUT59821A (en) 1992-07-28

Similar Documents

Publication Publication Date Title
DE69112975T2 (en) Geldüberweisungsgeraet.
DE69115052D1 (en) Gefässpfropfeneinführungsvorrichtung.
DE59105247D1 (en) Ballondilationskatheter.
DE69111667T2 (en) Röntgenstrahlenkollimationsvorrichtung.
DE69112585T2 (en) Irrigationssaugkanüle.
DE69016678T2 (en) Peroxycarbonsäuregenerator.
DE69100043T2 (en) Bilderzeugungsgeraet.
DE69112820D1 (en) Bogenentladungsableiter.
DE69110173D1 (en) Niederquerschnittsgurtversteller.
DE69102600T2 (en) Diffusionsschweissrepariertechnik.
DE69004083D1 (en) Polyalkylenglycolschmiermittelzusammensetzungen.
DE69107261T2 (en) Pipettenspülgefäss.
AT98487T (en) Aerosoltraeger.
DE484517T1 (en) Entlueftungssystem.
AT100704T (en) Peroxide-toothpastes.
DE481162T1 (en) Haushaltskochgeraet.
DE69102791T2 (en) Niederleistungsmetallhalogenidlampe.
DE69111425D1 (en) Brieffülleinrichtung.
DE69110565D1 (en) Schnellkupplungsanordung.
DE477080T1 (en) Datenuebertragungsgeraet.
DE69104392D1 (en) Spritzgisseinrichtung.
AT120022T (en) Food-automatic.
DE69113539T2 (en) Spiralrillengleitringdichtung.
DE69019140D1 (en) Full-year-tread.
DE69111512D1 (en) Impulsfeldkapillarelektrophorese.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties